Biliopancreatic Diversion
Obesity, Morbid
Vagotomy, Truncal
Bariatric Surgery
Gastric Bypass
Surgical procedure in which the STOMACH is transected high on the body. The resulting small proximal gastric pouch is joined to any parts of the SMALL INTESTINE by an end-to-side SURGICAL ANASTOMOSIS, depending on the amounts of intestinal surface being bypasses. This procedure is used frequently in the treatment of MORBID OBESITY by limiting the size of functional STOMACH, food intake, and food absorption.
Urinary Diversion
Temporary or permanent diversion of the flow of urine through the ureter away from the URINARY BLADDER in the presence of a bladder disease or after cystectomy. There is a variety of techniques: direct anastomosis of ureter and bowel, cutaneous ureterostomy, ileal, jejunal or colon conduit, ureterosigmoidostomy, etc. (From Campbell's Urology, 6th ed, p2654)
Jejunoileal Bypass
A procedure consisting of the SURGICAL ANASTOMOSIS of the proximal part of the JEJUNUM to the distal portion of the ILEUM, so as to bypass the nutrient-absorptive segment of the SMALL INTESTINE. Due to the severe malnutrition and life-threatening metabolic complications, this method is no longer used to treat MORBID OBESITY.
Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency. (1/54)
Raised plasma triglycerides (TGs) and nonesterified fatty acid (NEFA) concentrations are thought to play a role in the pathogenesis of insulin-resistant diabetes. We report on two sisters with extreme hypertriglyceridemia and overt diabetes, in whom surgical normalization of TGs cured the diabetes. In all of the family members (parents, two affected sisters, ages 18 and 15 years, and an 11-year-old unaffected sister), we measured oral glucose tolerance, insulin sensitivity (by the euglycemic-hyperinsulinemic clamp technique), substrate oxidation (indirect calorimetry), endogenous glucose production (by the [6,6-2H2]glucose technique), and postheparin plasma lipoprotein lipase (LPL) activity. In addition, GC-clamped polymerase chain reaction-amplified DNA from the promoter region and the 10 coding LPL gene exons were screened for nucleotide substitution. Two silent mutations were found in the father's exon 4 (Glu118 Glu) and in the mother's exon 8 (Thr361 Thr), while a nonsense mutation (Ser447 Ter) was detected in the mother's exon 9. Mutations in exons 4 and 8 were inherited by the two affected girls. At 1-2 years after the appearance of hyperchylomicronemia, both sisters developed hyperglycemia with severe insulin resistance. Because medical therapy (including high-dose insulin) failed to reduce plasma TGs or control glycemia, lipid malabsorption was surgically induced by a modified biliopancreatic diversion. Within 3 weeks of surgery, plasma TGs and NEFA and cholesterol levels were drastically lowered. Concurrently, fasting plasma glucose levels fell from 17 to 5 mmol/l (with no therapy), while insulin-stimulated glucose uptake, oxidation, and storage were all markedly improved. Throughout the observation period, plasma TG levels were closely correlated with both plasma glucose and insulin concentrations, as measured during the oral glucose tolerance test. These cases provide evidence that insulin-resistant diabetes can be caused by extremely high levels of TGs. (+info)Luminal dietary protein, not amino acids, induces pancreatic protease via CCK in pancreaticobiliary-diverted rats. (2/54)
We determined whether pancreatic adaptation to a high-protein diet depends on ingested protein in the intestinal lumen and whether such adaptation depends on a CCK or capsaicin-sensitive vagal afferent pathway in pancreaticobiliary-diverted (PBD) rats. Feeding a high-casein (60%) diet but not a high-amino acid diet to PBD rats increased pancreatic trypsin and chymotrypsin activities compared with those after feeding a 25% casein diet. In contrast, feeding both the high-nitrogen diets induced pancreatic hypertrophy in PBD rats. These pancreatic changes by the diets were abolished by treatment with devazepide, a CCK-A receptor antagonist. Protease zymogen mRNA abundance in the PBD rat was not increased by feeding the high-casein diet and was decreased by devazepide. Perivagal capsaicin treatment did not influence the values of any pancreatic variables in PBD rats fed the normal or high-casein diet. We concluded that luminal protein or peptides were responsible for the bile pancreatic juice-independent induction of pancreatic proteases on feeding a high-protein diet. The induction was found to be dependent on the direct action of CCK on the pancreas. Pancreatic growth induced by high-protein feeding in PBD rats may depend at least partly on absorbed amino acids. (+info)Vitamin A deficiency in a newborn resulting from maternal hypovitaminosis A after biliopancreatic diversion for the treatment of morbid obesity. (3/54)
BACKGROUND: Biliopancreatic diversion (BPD) has been advocated for the treatment of morbid obesity. This procedure has the theoretical advantage that patients retain normal eating capacity and lose weight irrespective of their eating habits. However, vitamin deficiencies may develop because BPD causes malabsorption. OBJECTIVE: This report describes a 40-y-old mother and her newborn infant, who developed vitamin A deficiency as a result of iatrogenic maternal malabsorption after BPD. Our primary objective is to show that BPD patients need close follow-up and lifelong micronutrient supplementation to prevent nutrient deficiencies in themselves and their offspring. DESIGN: The medical records of the mother and infant were reviewed, and their clinical course was followed until 10 mo postpartum. The mother was also interviewed on several occasions about her medical care, follow-up, and supplemental vitamin use. RESULTS: The mother developed night blindness with undetectable serum vitamin A concentrations in the third trimester of her pregnancy. Her vitamin A deficiency was untreated until she delivered her infant. At delivery, the infant also had vitamin A deficiency. He may have permanent retinal damage, but this is still unclear because the ophthalmologic examination performed at 2 mo of age was inconclusive. CONCLUSIONS: Complications of BPD may take many years to develop, and the signs and symptoms may be subtle. Because of the malabsorption that results from BPD, patients need lifelong follow-up and appropriate vitamin supplementation to prevent deficiencies. These nutrient deficiencies can also affect the offspring of female BPD patients. (+info)Potential of surgery for curing type 2 diabetes mellitus. (4/54)
OBJECTIVE: To review the effect of morbid obesity surgery on type 2 diabetes mellitus, and to analyze data that might explain the mechanisms of action of these surgeries and that could answer the question of whether surgery for morbid obesity can represent a cure for type 2 diabetes in nonobese patients as well. SUMMARY BACKGROUND DATA: Diabetes mellitus type 2 affects more than 150 million people worldwide. Although the incidence of complications of type 2 diabetes can be reduced with tight control of hyperglycemia, current therapies do not achieve a cure. Some operations for morbid obesity not only induce significant and lasting weight loss but also lead to improvements in or resolution of comorbid disease states, especially type 2 diabetes. METHODS: The authors reviewed data from the literature to address what is known about the effect of surgery for obesity on glucose metabolism and the endocrine changes that follow this surgery. RESULTS: Series with long-term follow-up show that gastric bypass and biliopancreatic diversion achieve durable normal levels of plasma glucose, plasma insulin, and glycosylated hemoglobin in 80% to 100% of severely obese diabetic patients, usually within days after surgery. Available data show a significant change in the pattern of secretion of gastrointestinal hormones. Case reports have also documented remission of type 2 diabetes in nonmorbidly obese individuals undergoing biliopancreatic diversion for other indications. CONCLUSIONS: Gastric bypass and biliopancreatic diversion seem to achieve control of diabetes as a primary and independent effect, not secondary to the treatment of overweight. Although controlled trials are needed to verify the effectiveness on nonobese individuals, gastric bypass surgery has the potential to change the current concepts of the pathophysiology of type 2 diabetes and, possibly, the management of this disease. (+info)Reduced expression of uncoupling proteins-2 and -3 in adipose tissue in post-obese patients submitted to biliopancreatic diversion. (5/54)
OBJECTIVE: Little is known about the physiological role and the regulation of uncoupling proteins-2 and -3 (UCP-2 and -3) in adipose tissue. We investigated whether the expression of UCP-2 and -3 in adipose tissue was affected by weight loss due to a biliopancreatic diversion (BPD) and related to the daily energy expenditure (24-h EE). DESIGN: Ten morbidly obese subjects (mean body mass index +/- s.e.m.=49.80 +/- 2.51 kg/m(2)) were studied before and 18+/-2 Months after BPD. METHODS: We determined body composition using tritiated water and 24-h EE in a respiratory chamber. Adipose tissue UCP-2 and -3 mRNA, plasma insulin, glucose, free fatty acids (NEFA), free triiodothyronine (FT3), free thyroxine (FT4) and leptin were assayed before and after BPD. RESULTS: BPD treatment resulted in a marked weight loss (P<0.001) mainly due to a fat mass reduction. A significant decrease in 24-h EE/fat-free mass (FFM) (P<0.05) and in UCP-2 (P<0.05) and UCP-3 (P<0.05) mRNA was observed. A significant reduction in plasma insulin, glucose, NEFA, FT3, FT4 and leptin was seen after BPD. The decline in plasma leptin and FFA was tightly correlated with the decrease in both UCP-2 and -3. A significant correlation was found between changes in FT3 and variations in 24-h EE (r=0.64, P<0.05). In a multiple-regression analysis changes in 24-h EE/FFM after BPD were significantly correlated with changes in UCP-3 expression (P<0.05). CONCLUSION: These findings suggest that UCPs in adipose tissue may play a role in the reduction in 24-h EE observed in post-obese individuals. (+info)The duodenal switch operation for the treatment of morbid obesity. (6/54)
OBJECTIVE: To determine the safety and efficacy of the duodenal switch procedure as surgical treatment of morbid obesity. SUMMARY BACKGROUND DATA: The longitudinal gastrectomy and duodenal switch procedure as performed for morbid obesity involves a 75% subtotal greater curvature gastrectomy and long limb suprapapillary Roux-en-Y duodenoenterostomy. This results in a restricted caloric intake and diversion of bile and pancreatic secretions to induce fat malabsorption. Broad acceptance of this procedure has been impeded because of concerns that the malabsorptive component may produce serious nutritional complications. METHODS: Review of data collected prospectively from all patients who underwent duodenal switch as the primary surgical treatment of morbid obesity at a single institution during the 10-year period beginning September 1992. Operative morbidity and mortality, weight loss, volume of food intake, and bowel function were recorded. Sequential measurements of serum albumin, hemoglobin, and calcium levels were obtained to assess metabolic function and nutrient absorption. RESULTS: Duodenal switch was performed as the primary operation in 701 (81%) of a total 863 patients undergoing bariatric surgery during the period of study. The average body mass index (BMI) was 52.8 (range, 34-95). Perioperative mortality was 1.4%, and morbidity (including leaks, wound dehiscence, splenectomy, and postoperative hemorrhage) occurred in 21 patients (2.9%). Weight loss averaged 127 pounds at 1 year, 131 at 3 years, and 118 at 5 or more years (% EBWL of 69%, 73%, and 66%, respectively). The mean number of bowel movements was fewer than 3 per day. Patients reported and maintained a mean restriction of 63% of their preoperative intake (approximately 1600 calories), with no specific food intolerance, at 3 or more years follow-up. At 3 years, serum albumin remained at normal levels in 98% of patients, hemoglobin in 52%, and calcium in 71%. No patients reported dumping, and marginal ulcers were not seen. CONCLUSIONS: The longitudinal gastrectomy with duodenal switch is a safe and effective primary procedure for the treatment of morbid obesity. It has the advantage of allowing acceptable alimentation with a minimum of side effects while producing and maintaining significant weight loss. These results are achieved without developing significant dietary restrictions or clinical metabolic or nutritional complications. (+info)Surgical treatment of obesity: a review. (7/54)
Obesity is a chronic disease due to excess fat storage, a genetic predisposition, and strong environmental contributions. This problem is worldwide, and the incidence is increasing daily. There are medical, physical, social, economic, and psychological comorbid conditions associated with obesity. There is no cure for obesity except possibly prevention. Nonsurgical treatment has been inadequate in providing sustained weight loss. Currently, surgery offers the only viable treatment option with longterm weight loss and maintenance for the morbidly obese. Surgeries for weight loss are called bariatric surgeries. There is no one operation that is effective for all patients. Gastric bypass operations are the most common operations currently used. Because there are inherent complications from surgeries, bariatric surgeries should be performed in a multidisciplinary setting. The laparoscopic approach is being used by some surgeons in performing the various operations. The success rate--usually defined as >50% excess weight loss that is maintained for at least five years from bariatric surgery--ranges from 40% in the simple to >70% in the complex operations. The weight loss from surgical treatment results in significant improvements and, in some cases, complete resolution of comorbid conditions associated with obesity. Patients undergoing surgery for obesity need lifelong nutritional supplements and medical monitoring. (+info)Biliopancreatic tumors: patient survival and quality of life after palliative treatment. (8/54)
OBJECTIVES: to analyse survival and quality of life of patients with malignant obstructive jaundice after palliative treatment, comparing endoscopic stent insertion and palliative surgical (palliative resection and bypass surgical). PATIENTS AND METHOD: eighty and seven patients were included in a trial. They were distributed to endoscopic stent (50) and palliative surgical (37). It analysed survival, quality of life and comfort index of jaundiced patients. The good quality of life was defined by absence of jaundice, pruritus and cholangitis after the initial treatment. RESULTS: the median survival of the patients treated to endoscopic stent was 9,6 months whereas the patients to surgical treatment survived a median of 17 months. The time free of disease was 4 months in stented patients and 10,5 months in surgical patients. There was no significant difference in comfort index between the two groups (stented 34%, surgical 42,5%) Neither was there significant difference in survival and quality of life between palliative resection and bypass surgery. CONCLUSIONS: despite the survival and time free of disease being better in surgical patients, there was no significant difference in overall quality of life between the two groups. The survival and quality of life are the same after palliative resection as after bypass surgery, for this should not be performed routinely or to justify resection as a debulking procedure. (+info)Biliopancreatic Diversion with Duodenal Switch, or BPD
Routine cholecystectomy during laparoscopic biliopancreatic diversion with duodenal switch is not necessary
Biliopancreatic Diversion | Advanced Laparoscopic Surgery Associates Medical Group, Inc.
General Information - Operation techniques - FAQ - Dr. med. Thomas Köstler - Bariatric Surgery
Operation techniques - Dr. med. Thomas Köstler - Bariatric Surgery
Biliopancreatic Diversion with Duodenal Switch (BPD-DS) Weight-Loss Surgery
Biliopancreatic Diversion with Duodenal Switch (BPD-DS) Weight-Loss Surgery
Gastric bypass or biliopancreatic diversion increases remission from type 2 diabetes in obese adults | Annals of Internal...
Weight Loss Pictures - A Definitive Guide to Weight Loss: Dr. Khalid Mirza Gari performing the BPD (Biliopancreatic Diversion)
Increased Bile Acid Synthesis and Deconjugation After Biliopancreatic Diversion | Diabetes
Retro-Roux Biliopancreatic Limb: A Case Report and Technique For Repair - SAGES Abstract Archives
What is a Duodenal Switch Procedure?
Weight Loss Pictures - A Definitive Guide to Weight Loss: Sleeve Gastrectomy With Duodenal Switch
Rex Bariatric Specialists Raleigh | Bilio-Pancreatic Diversion with Duodenal Switch
Serum fat-soluble vitamin deficiency and abnormal calcium metabolism after malabsorptive bariatric surgery. - PubMed - NCBI
New Frontiers on Bariatric Surgical Procedures: Classical Bypass for Type-2 Diabetic Patients With Obesity Grade I - Full Text...
Bariatric Surgery to reduce obesity | Find Me A Cure
BPD/DS betters RYGB in super obese patients | Bariatric News
Is Bariatric Surgery an Effective Treatment for Type II Diabetic Kidney Disease? | American Society of Nephrology
Bariatric Surgery on the West Coast of Norway (Vestlandet) - Full Text View - ClinicalTrials.gov
Skinnyjab | Glamour Weight Loss | Weight Loss Frequency | Weight Loss Flyer
Diabetes Meter: January 2012
Health Train Express: Weight Loss on the Health Train Express
Authors response | British Journal of Ophthalmology
sg:pub.10.1007/s002689900498 - Springer Nature SciGraph
Gastroenterologist in Ahmedabad - List of Best Gastroenterologist | Lybrate
Laparoscopy in bilio-pancreatic surgery in elderly | BMC Geriatrics | Full Text
Post Operative Guide for Duodenal Switch - Mexico Bariatric Center
Duodenal Switch Average Weight Loss
Loop Duodenal Switch « Laparoscopy International
Articles Archive - Duodenal Switch
Pre-Operative Care Archives - Duodenal Switch
Duodenal switch
20th Düsseldorf International Endoscopy Symposium
| HealthManagement.org
Oncologic Surgery - Alagsa
pancreatobiliary - GIHEP
Meetings
What Are Your Bariatric Surgery Options?- Bariatric Fusion
On the Impact of Bariatric Surgery on Glucose Homeostasis
GLP1 analogs as treatment of postprandial hypoglycemia following gastric bypass surgery : a potential new indication?
Growth hormone and ghrelin secretion in severely obese women before and after bariatric surgery.
Bowel-Associated Dermatosis-Arthritis Syndrome | Springer for Research & Development
Duodenal Switch Surgery - Tijuana Bariatrics Center - Start the Journey Now
Artemis : Centres of Excellence
NewYork-Presbyterian Queens - Study Finds Obesity Switch Surgery More Effective
Duodenal Switch Surgery Better Against Type 2 Diabetes Than Gastric Bypass | Diabetes Health
Gastric Reduction Duodenal Switch Surgery | Travcure
Worlds heaviest man recovering from bypass surgery | Juan Pedro Franco | obesity | Heaviest | NTD.TV
NewYork-Presbyterian Queens - Gastric Bypass (Malabsorptive) Surgery
Meireles O
Life After DS
ifso - Obesity Online
The City of Toronto rolls out its waste diversion program | ...
Industrial, Commercial, Institutional (ICI) Waste Diversion | The Town of Okotoks
Diversion Number 1 | The Anarchist Library
pancreatobiliary tract cytology - Humpath.com - Human pathology
Diversion | Clark County
Cigar Smoking Diversion PrestaShop Theme #51993
Halos: A slight diversion for gsgs
Intestinal bypass
Malabsorption is especially prominent in biliopancreatic diversion. Not only does it reduce the length of the small intestine ... They are jejunocolic bypass, end-to-side jejunoileal bypass, end-to-end jejunoileal bypass, and biliopancreatic diversion, ... First appeared in 1980, biliopancreatic diversion involves two parts: gastrectomy and intestinal bypass. Firstly, gastrectomy ... "Vitamin D Status and Bone Histomorphometry after Biliopancreatic Bypass for Obesity". Clinical Science. 67 (s9): 73P.2-73P. doi ...
Bowel-associated dermatosis-arthritis syndrome
BADAS has also been reported following biliopancreatic diversion (a form of bariatric surgery, also known as Scopinaro ... "Bowel-associated dermatosis-arthritis syndrome after biliopancreatic diversion". Obes Surg. 14 (1): 133-5. doi:10.1381/ ...
Bariatric surgery
Main Article: biliopancreatic diversion with duodenal switch A slightly less common bariatric procedure, accounting for less ... This operation is termed biliopancreatic diversion (BPD) or the Scopinaro procedure. The original form of this procedure is now ... Biliopancreatic diversion - 117 Lbs / 53 kg, Roux-en-Y gastric bypass (RYGB) - 90 Lbs / 41 kg, Open - 95 Lbs/ 43 kg, ... and biliopancreatic diversion with duodenal switch) is largely achieved by altering gut hormone levels responsible for hunger ...
Duodenal switch
The traditional biliopancreatic diversion with duodenal switch (BPD-DS) led to persistent malnutrition in a subset of patients ... The much longer pathway, the biliopancreatic loop, carries bile from the liver to the common channel. The common channel is the ... in which the contents of the digestive path mix with the bile from the biliopancreatic loop before emptying into the large ...
Gastric bypass surgery
... or biliopancreatic diversion/duodenal switch procedures. In these procedures, fat absorption is markedly impaired. There is ... mimicking the effects of the biliopancreatic portion of Roux-en-Y gastric bypass (RYGB) surgery. Despite a handful of serious ...
Obesity
... and biliopancreatic diversion. Surgery for severe obesity is associated with long-term weight loss, improvement in obesity- ...
Obesity and fertility
A small study of 17 women with PCOS revealed that a vast majority improved upon undergoing either biliopancreatic diversion or ...
Adjustable gastric band
Unlike more open forms of weight loss surgery (e.g. Roux-en-Y gastric bypass surgery (RNY), Biliopancreatic diversion (BPD) and ...
BPD
... may refer to: Borderline personality disorder Bipolar disorder Brief psychotic disorder Biliopancreatic diversion ...
List of MeSH codes (E04)
... biliopancreatic diversion MeSH E04.210.219 - colectomy MeSH E04.210.219.620 - proctocolectomy, restorative MeSH E04.210.240 - ... biliopancreatic diversion MeSH E04.210.120.172 - cholecystectomy MeSH E04.210.120.172.140 - cholecystectomy, laparoscopic MeSH ... urinary diversion MeSH E04.950.774.852.240 - cystostomy MeSH E04.950.774.852.642 - nephrostomy, percutaneous MeSH E04.950. ...
Biliopancreatic diversion (BPD): MedlinePlus Medical Encyclopedia Image
... such as biliopancreatic diversion (BPD), restrict both food intake and the amount of calories and nutrients the body absorbs. ... Malabsorptive operations, such as biliopancreatic diversion (BPD), restrict both food intake and the amount of calories and ... Biliopancreatic diversion (BPD). URL of this page: //medlineplus.gov/ency/imagepages/19499.htm Biliopancreatic diversion (BPD) ...
Biliopancreatic Diversion with Duodenal Switch | Gastric Bypass
Duodenal Leiomyoma found During Robotic-Laporoscopic Biliopancreatic Diversion with Duodenal Switch from the SAGES Video Library
Biliopancreatic diversion with a duodenal switch Archives - Blog - HealthifyMe
At the heart of HealthifyMes platform is the Worlds First & largest Indian Calorie Tracker, which allows users to track their food, exercise and weight, easily via their smartphone or computer while continuously analyzing the users data and provide powerful insights that ensure that users stay within their calorie/nutrition budgets ...
Further lowering of muscle lipid oxidative capacity in obese subjects after biliopancreatic diversion<...
Further lowering of muscle lipid oxidative capacity in obese subjects after biliopancreatic diversion. In: Journal of Clinical ... Further lowering of muscle lipid oxidative capacity in obese subjects after biliopancreatic diversion. Journal of Clinical ... Further lowering of muscle lipid oxidative capacity in obese subjects after biliopancreatic diversion. / Fabris, R.; Mingrone, ... title = "Further lowering of muscle lipid oxidative capacity in obese subjects after biliopancreatic diversion", ...
Biliopancreatic Diversion Archives - Modern Health Issues
Welcome to Modern Health Issues. We believe that your health is your number one asset.. The world of health is a large one, with many facets to cover. We bring you information and news on current health issues, including diet, fitness, and nutrition; medicine, wellness, alternative health; resources for healthy living, and more.. We hope you enjoy your visit, and hope you find something here to inspire you to greater health!. ...
Biliopancreatic diversion with a duodenal switch - Delhi Obesity
Bilio-Pancreatic Diversion With Duodenal Switch (BPD-DS)
Bariatric Surgery Treatment & Management: Approach Considerations, Medical Therapy, Surgical Therapy
Biliopancreatic diversion with duodenal switch. Biliopancreatic diversion with duodenal switch (see the image below) includes ... Biliopancreatic diversion with duodenal switch. Because the biliopancreatic diversion with duodenal switch procedure is less ... Effectiveness of laparoscopic sleeve gastrectomy (first stage of biliopancreatic diversion with duodenal switch) on co- ... from the biliopancreatic secretions, which pass through the biliopancreatic limb of the Y. The degree of malabsorption can be ...
Obesity: Practice Essentials, Background, Pathophysiology
Mid-Life Weight Gain Anne Collins
ROBOTIC, LAPAROSCOPIC BILIOPANCREATIC DIVERSION WITH DUODENAL SWITCH (BPD DS, DUODENAL SWITCH) - Dr. V Amar
WHAT IS BILIOPANCREATIC DIVERSION WITH DUODENAL SWITCH (BPD DS)? - One of the most advanced and effective bariatric & metabolic ... Diversion of the biliopancreatic juices contribute further to these physiological changes.. - Role of food restriction and ... WHAT ARE THE LIMITATIONS OF BILIOPANCREATIC DIVERSION WITH DUODENAL SWITCH? - BPD DS is technically more advanced, complex and ... Physiological changes are very high in Biliopancreatic diversion with duodenal switch as longer small intestine is bypassed ...
The Pre-approval Process - Obesity Action Coalition
Apollo Spectra Hospitals - Alwarpet in Chennai, India
Patrick R. Reardon, MD FACS | ACS Profile | ACS
Long-Term Follow-Up Study of Liver-Related Outcome After Bilio-Pancreatic Diversion in Patients with Initial, Significant Liver...
Long-Term Follow-Up Study of Liver-Related Outcome After Bilio-Pancreatic Diversion in Patients with Initial, Significant Liver ... Methods: This study included 56 NAFLD patients who underwent bilio-pancreatic diversion for morbid obesity and who had ... Methods: This study included 56 NAFLD patients who underwent bilio-pancreatic diversion for morbid obesity and who had ... Thus, preexisting liver damage does not seem to be a contraindication to bilio-pancreatic diversion. ...
Angina
Appendix C
Complications of antiobesity surgery
Obesity: Practice Essentials, Background, Pathophysiology
BariatricPal Sugar-Free Calcium Citrate Soft Chews 500mg with Probioti
HOSPITALS : Health Medical Information : MedExplorer - Health, Medical Network Since 1995
HealthCare Belgium - Interventions
Laparoscopic roux-en-y gastric bypass: Principles and procedures<...
1999; Schirmer 2000), and the biliopancreatic diversion with duodenal switch. The RYGBP has been used most widely in the USA ... 1999; Schirmer 2000), and the biliopancreatic diversion with duodenal switch. The RYGBP has been used most widely in the USA ... 1999; Schirmer 2000), and the biliopancreatic diversion with duodenal switch. The RYGBP has been used most widely in the USA ... 1999; Schirmer 2000), and the biliopancreatic diversion with duodenal switch. The RYGBP has been used most widely in the USA ...
Results matching topic of vsa | Page 1 of 2 | HealthData.gov
Results matching topic of utilization | Page 1 of 3 | HealthData.gov
Experience report: 3D laparoscopy - use in bariatric surgery
Biliopancreatic Diversion for Severe Obesity: Long-Term Effectiveness and Nutritional Complications. Obes Surg. 2015 May 17. [ ... So, the single-anastomosis gastric bypass (omega loop), the biliopancreatic diversion with a duodenal switch (BPDDS) and even ... Lengthening of the biliopancreatic limb is a key step during revisional Roux-en-Y gastric bypass for weight regain and diabetes ...